CG Invites Co., Ltd.

KOSDAQ:A083790 Stock Report

Market Cap: ₩76.1b

CG Invites Past Earnings Performance

Past criteria checks 0/6

CG Invites's earnings have been declining at an average annual rate of -16.7%, while the Biotechs industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 24.3% per year.

Key information

-16.70%

Earnings growth rate

-14.36%

EPS growth rate

Biotechs Industry Growth11.70%
Revenue growth rate24.29%
Return on equity-12.28%
Net Margin-14.10%
Last Earnings Update31 Mar 2026

Recent past performance updates

Recent updates

Analysis Article Dec 01

Would CG Invites (KOSDAQ:083790) Be Better Off With Less Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Aug 12

We Think CG Invites (KOSDAQ:083790) Has A Fair Chunk Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Mar 19

CrystalGenomics Invites Co., LTD.'s (KOSDAQ:083790) Share Price Is Matching Sentiment Around Its Revenues

With a price-to-sales (or "P/S") ratio of 7.2x CrystalGenomics Invites Co., LTD. ( KOSDAQ:083790 ) may be sending...
Analysis Article Jan 28

Is CrystalGenomics (KOSDAQ:083790) Using Debt Sensibly?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Dec 06

Update: CrystalGenomics (KOSDAQ:083790) Stock Gained 57% In The Last Five Years

CrystalGenomics, Inc. ( KOSDAQ:083790 ) shareholders might be concerned after seeing the share price drop 19% in the...

Revenue & Expenses Breakdown

How CG Invites makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A083790 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2629,221-4,12011,5994,166
31 Dec 2527,391-3,52112,1564,424
30 Sep 2517,500-48,72025,63110,307
30 Jun 2513,002-43,88623,81411,102
31 Mar 259,003-47,83524,02110,205
31 Dec 247,253-51,54424,03511,318
30 Sep 245,574-61,04921,0848,471
30 Jun 244,558-33,92223,9437,747
31 Mar 243,739-50,09623,7627,784
31 Dec 234,879-47,09323,8357,182
30 Sep 23-6,192-23,1159,8366,493
30 Jun 23-1,726-47,68214,9946,538
31 Mar 23-2,032-23,34215,6796,216
31 Dec 224,321-21,65817,0026,305
30 Sep 2237,556-29,99328,8805,840
30 Jun 2240,631-25,94724,4115,915
31 Mar 2243,839-19,65722,2925,688
31 Dec 2142,376-15,90121,5664,859
30 Sep 21-65,378-18,30810,6534,158
30 Jun 21-39,375-2,44213,4122,741
31 Mar 21-4,812-4,49915,9212,779
31 Dec 2030,223-12,88516,1474,980
30 Sep 20125,485-25,51923,0845,471
30 Jun 2092,402-44,83118,2075,471
31 Mar 2054,619-46,25113,9295,471
31 Dec 1914,007-37,6169,1914,849
30 Sep 199,3133554,8413,269
30 Jun 199,0903,3604,5943,269
31 Mar 1914,0209,5884,7003,473
31 Dec 1813,8876,8604,9953,435
30 Sep 189,466-4,8725,6966,295
30 Jun 1812,471-3,2055,6406,295
31 Mar 189,668-8,4226,9086,192
31 Dec 1712,175-8,5756,9487,539
30 Sep 1710,887-7,0661,64112,052
30 Jun 1710,530-7,7382,09212,052
31 Mar 1713,459-5,1281,98210,918
31 Dec 1614,525-1,9605,9807,066
30 Sep 1615,3571,0065,4306,102
30 Jun 1614,4337695,0746,102
31 Mar 169,120-1,6734,0886,102
31 Dec 156,136-4,9922,9566,102
30 Sep 156,831-8,45410,0956,558

Quality Earnings: A083790 is currently unprofitable.

Growing Profit Margin: A083790 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A083790 is unprofitable, and losses have increased over the past 5 years at a rate of 16.7% per year.

Accelerating Growth: Unable to compare A083790's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A083790 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (22.6%).


Return on Equity

High ROE: A083790 has a negative Return on Equity (-12.28%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 09:05
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CG Invites Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
JooYong KimBookook Securities Co. Ltd
Jae Hoon ShinLS Securities Co., Ltd.
Hyun-Tae KimMirae Asset Securities Co., Ltd.